Systems and methods for determining a flow speed of a fluid flowing through a cardiac assist device

Information

  • Patent Grant
  • 12310708
  • Patent Number
    12,310,708
  • Date Filed
    Thursday, June 6, 2019
    5 years ago
  • Date Issued
    Tuesday, May 27, 2025
    2 days ago
Abstract
The invention relates to a method for determining at least a flow velocity or a fluid volume flow (5) of a fluid flowing through an implanted vascular support system (1), comprising the following steps: a) carrying out a pulsed Doppler measurement by means of an ultrasonic sensor (2) of the support system (1), b) evaluating a measurement result from step a), which has a possible ambiguity, c) providing at least one operating parameter of a flow machine (3) of the support system (1), d) determining at least the flow velocity or the fluid volume flow (5) using the measurement result evaluated in step b), wherein the possible ambiguity of the measurement result is corrected using the operating parameter.
Description
BACKGROUND
Field

The invention relates to a method for determining a flow velocity of a fluid flowing through an implanted vascular support system, an implantable vascular support system, and a use of an operating parameter of a flow machine of an implanted vascular support system. The invention is in particular used in (fully) implanted left-heart support systems (LVAD).


Description of the Related Art

It is known to integrate ultrasonic volume flow sensors into heart support systems in order to therewith detect the so-called pump volume flow, which quantifies the fluid volume flow through the support system itself. The ultrasonic volume flow sensors can carry out pulsed Doppler measurements or use the pulsed Doppler (pulsed wave Doppler; in short: PWD) method. This method requires only one ultrasound transducer element and allows precise selection of the distance of the observation window from the ultrasound element.


The task of a cardiac support system is to convey blood. In this case, the so-called heart-time volume (HTV, usually indicated in liters per minute) is highly clinically relevant. In other words, the heart-time volume in this case relates to the total volume flow of blood from a ventricle, in particular from the left ventricle, to the aorta. Correspondingly clear is the attempt to collect this parameter as a measured value during operation of a cardiac support system.


Depending on the level of support, which describes the proportion of volume flow conveyed by a conveying means, such as a pump of the support system, to the total volume flow of blood from the ventricle to the aorta, a certain volume flow reaches the aorta via the physiological path through the aortic valve. The heart-time volume or the total volume flow (QHTV) from the ventricle to the aorta is therefore usually the sum of the pump volume flow (Qp) and the aortic valve volume flow (Qa).


An established method for the determination of the heart-time volume (QHTV) in the clinical setting is the use of dilution methods, which, however, all rely on a catheter inserted transcutaneously and therefore can only provide heart-time volume measurement data during cardiac surgery and during the subsequent stay in intensive care. For high levels of support, Qa approaches zero so that approximately Qp≈QHZV applies. Accordingly, at least in these cases, the heart-time volume can be determined at least approximately via the pump volume flow. An established method for measuring the pump volume flow (Qp) is the correlation of the operating parameters of the support system, predominantly the electrical power consumption, possibly supplemented by further physiological parameters, such as the blood pressure. Since these methods are based on statistical assumptions and the underlying pump characteristic map of the support system used, the correlated Qp are error-prone. In order to increase the measurement quality of the parameter Qp, the inclusion of a flow sensor is therefore desirable.


A particularly suitable sensor method for determining flow velocities and thus also volume flows is ultrasound, in particular the pulsed wave Doppler method (PWD) since it requires only one bidirectional ultrasound transducer element and allows precise selection of the distance of the observation window in which the measured values are collected. It is thus possible to carry out the flow velocity measurement in the range in which suitable flow conditions prevail.


In a PWD system, ultrasonic pulses are sent out at a defined pulse repetition rate (PRF). If the flow velocity and flow direction are unknown, the PRF must exceed at least twice the maximum occurring Doppler frequency shift in order to not violate the Nyquist theorem. If this condition is not met, aliasing occurs, i.e., ambiguities in the determined frequency spectrum. When detecting a frequency in the frequency spectrum, it can no longer be unambiguously assigned to one but several flow velocities.


Due to the geometric design of the measurement setup in heart support systems (VAD), the measurement range or the observation window may be so far away from the ultrasound transducer that the signal transit time of the ultrasonic pulse from the transducer to the measurement range and back to the transducer is not negligible. Since a new ultrasonic pulse may only be sent out if the preceding one no longer delivers significant echoes, the signal transit time limits the maximum possible PRF. In the case of the high flow velocities prevailing in heart support systems and the geometric boundary conditions for the distance of the observation window from the ultrasound element, there is inevitably a violation of the Nyquist sampling theorem, which results in ambiguities being produced in the spectrum.


Heart support systems with ultrasonic sensors that do not use the PWD method are usually equipped with two ultrasound transducers so that the described transit time problem can occur but can be solved otherwise with appropriate implementation. However, heart support systems with ultrasonic sensors that use the PWD method are susceptible to the described effect, in particular in the case of moderate to high flow velocities. The current state of the art is the measure to select the defined pulse repetition rate such that aliasing does not occur or to suitably adjust, if possible, both the geometric conditions and the ultrasound frequency.


SUMMARY

The object of the invention is to specify an improved method for determining a flow velocity of a fluid flowing through an implanted vascular support system and to create an improved implantable vascular support system in which the flow velocity of a fluid flowing through it can be determined.


In particular, it is an object of the invention to create a method for determining a flow velocity of a fluid and an improved implantable vascular support system, in which the determination of the flow velocity of a fluid flowing through it is provided, in which the determination of the flow velocity at the flow velocities prevailing in a heart support system is possible with only one ultrasound transducer, even in the case of a long signal transit time of an ultrasonic pulse from the ultrasound transducer to the measurement range and back.


This object is achieved by the systems and methods disclosed herein.


Advantageous embodiments of the invention are specified herein.


In some embodiments, a method for determining at least a flow velocity or a fluid volume flow of a fluid flowing through an implanted vascular support system is proposed here, comprising the following steps:

    • a) carrying out a pulsed Doppler measurement by means of an ultrasonic sensor of the support system,
    • b) evaluating a measurement result from step a), which has a possible ambiguity,
    • c) providing at least one operating parameter of a flow machine of the support system,
    • d) determining at least the flow velocity or the fluid volume flow using the measurement result evaluated in step b),
    • wherein the possible ambiguity of the measurement result is corrected using the operating parameter.


The vascular support system is preferably a cardiac support system, particularly preferably a ventricular support system. The support system is regularly used to support the conveyance of blood in the blood circulation of a person, if appropriate patients. The support system can be arranged at least partially in a blood vessel. The blood vessel is, for example, the aorta, in particular in the case of a left-heart support system, or the common trunk (Truncus pulmonalis) into the two pulmonary arteries, in particular in the case of a right-heart support system. The support system is preferably arranged at the exit of the left ventricle of the heart or the left heart chamber. The support system is particularly preferably arranged in the aortic valve position.


The solution proposed here contributes in particular to providing an aliasing compensation method for an ultrasonic volume flow sensor in a heart support system. The method can contribute to determining a fluid flow velocity and/or a fluid volume flow from a ventricle of a heart, in particular from a (left) ventricle of a heart, to the aorta in the region of a (fully) implanted (left) ventricular (heart) support system. The fluid is regularly blood. The flow velocity is determined in a fluid flow or fluid volume flow, which flows through the support system, in particular through an (inlet) tube or an (inlet) cannula of the support system. The method advantageously allows the flow velocity and/or the fluid volume flow of the blood flow to be determined with high quality even outside the surgical scenario, in particular by the implanted support system itself.


The solution proposed here can particularly advantageously use the fact that based on the motor characteristic map, a rough estimation of the pump flow is possible (only) from the rotation rate of the drive or on the basis of the differential pressure across the flow machine and the rotation rate. The in particular rough estimate of the flow rate from the operating parameters of the flow machine is used in particular to resolve the ambiguities in the spectrum and to enable highly precise flow measurement by the ultrasonic sensor.


In step a), a pulsed Doppler measurement is carried out by means of an ultrasonic sensor of the support system. In order to carry out the pulsed Doppler measurement, the pulsed Doppler (pulsed wave Doppler; in short: PWD) method is in particular used. In particular, a PWD measurement cycle is run through in step a).


In step b), a measurement result from step a) which has a possible ambiguity is evaluated. “Possible ambiguity” means in other words in particular that the measurement result or all measurement results do not necessarily always have to have an ambiguity. In particular, in the case of a comparatively high flow velocity, as commonly occurring in the support systems in question here, the measurement result generally has an ambiguity. However, at a comparatively low flow velocity, it can also happen that the measurement result is unambiguous.


The measurement result can furthermore be provided in particular after step b). In this case, the measurement result can, for example, be provided as raw data (e.g., frequency spectrum) or as raw measurement result or as already at least partially preprocessed measurement result (e.g., as a (measured) flow velocity and/or as a (measured) fluid volume flow). The measurement result can be provided to a processing unit of the support system, for example.


In step c), at least one operating parameter of a flow machine of the support system is provided. The operating parameter can be provided to a processing unit of the support system, for example. The measurement result provided in step b) and the operating parameter provided in step c) are generally detected with respect to the same fluid flow, e.g., in the same (temporal and/or spatial) observation window. In other words, this means in particular that the measurement result provided in step b) and the operating parameter provided in step c) relate to substantially the same measurement time or have substantially the same time stamp and/or relate to the same measuring point. In this case, “substantially” in particular describes a deviation of less than one second. A time difference (generally of less than one second) can be taken into account until the operating parameter (or a change thereof) affects the measuring point. This can also be described in such a way that the measurement result provided in step b) and the operating parameter provided in step c) are associated with each other. At least one operating parameter associated with the measurement result provided in step b) is preferably provided in step c).


In step d), the (actual) flow velocity is determined using the measurement result evaluated in step b). If a raw measurement result is evaluated in step b) and then provided, it is particularly advantageous if a (measured) flow velocity is determined therefrom (e.g., in step d). If a pre-processed measurement result for a (measured) flow velocity is provided in step b), it can advantageously be used directly in step d). The (measured) flow velocity is generally not unambiguous. Furthermore, it is advantageous if an estimated flow velocity is determined on the basis of the operating parameter provided in step c). The (actual) flow velocity can now be determined, for example, by selecting the measured flow velocity that is closest to the estimated flow velocity.


Alternatively or cumulatively, an (actual) fluid volume flow (instead of the flow velocity) can be determined in step d). If a raw measurement result is provided in step b), it is particularly advantageous if a (measured) fluid volume flow is determined therefrom. If a pre-processed measurement result for a (measured) fluid volume flow is provided in step b), it can advantageously be used directly in step d). The (measured) fluid volume flow is generally not unambiguous. Furthermore, it is advantageous if an estimated fluid volume flow is determined on the basis of the operating parameter provided in step c). The (actual) flow volume flow can now be determined, for example, by selecting the measured fluid volume flow that is closest to the estimated fluid volume flow.


In the sense of the solution proposed here, the possible ambiguity of the measurement result is corrected or resolved using the operating parameter. The measurement result is generally ambiguous. This ambiguity can be explained in particular by the generally present violation of the Nyquist sampling theorem in this case. This violation of the Nyquist sampling theorem is caused in particular by comparatively long signal transit times existing in the support system between the ultrasonic sensor and the observation window or measurement range and a new ultrasonic pulse in the pulsed Doppler measurements generally being sent out only if the echo of an ultrasonic pulse sent out immediately beforehand was received or has died away.


The possible ambiguity can, for example, be corrected or resolved in step d). In this context, the flow velocity can be determined in step d) using the (possibly ambiguous) measurement result evaluated and/or provided in step b) and the operating parameter provided in step c), wherein the possible ambiguity of the measurement result is corrected using the operating parameter. A possibility to carry out such a correction or to resolve a possible ambiguity has already been described above. By way of example, the measured flow velocity or the measured fluid volume flow that is closest to the estimated flow velocity or the estimated fluid volume flow is selected in this case.


Alternatively, the possible ambiguity can (already) be corrected or resolved in step b), for example. This alternative can also be referred to as a priori estimation or as a priori selection or pre-selection. In other words, this means in particular that the possible ambiguity is already corrected or resolved during the evaluation of the measurement result. This can be particularly advantageous take place such that (only) the range or section of the (raw) measurement result in which a plausible result is to be expected is evaluated. The evaluated (no longer ambiguous) measurement result can in this case be provided in step b). The evaluated (no longer ambiguous) measurement result can in this case be used in step d).


“A priori” here means in particular that the operating parameter is provided and/or the estimated flow velocity or the estimated fluid volume flow is determined before the (possibly ambiguous) measurement result is evaluated (and, if applicable, provided). For example, the operating parameter, the a priori estimated flow velocity and/or the a priori estimated fluid volume flow (possibly in the form of a window function or windowing) can contribute to a pre-selection in order to evaluate and/or provide only a plausible measurement result or only the plausible part of the measurement result. For this purpose, a (reflected and then) received ultrasonic pulse can, for example, only be evaluated in the (frequency) section in which a plausible result is to be expected.


According to an advantageous embodiment, it is proposed that a new ultrasonic pulse is only sent out in step a) if an echo of an ultrasonic pulse sent out immediately beforehand has (sufficiently) died away and/or was received. A new ultrasonic pulse is preferably sent out only if all (significant) echoes of an ultrasonic pulse sent out immediately beforehand have (sufficiently) died away and/or were received. A new ultrasonic pulse is furthermore preferably sent out only if the (significant) echoes of an ultrasonic pulse sent out immediately beforehand from a (predefined) measurement window or measurement range have (sufficiently) died away and/or were received.


According to an advantageous embodiment, it is proposed that a maximum pulse repetition rate of the pulsed Doppler measurement is less than two times a maximum occurring Doppler shift. The maximum pulse repetition rate of the pulsed Doppler measurements is preferably less than the maximum occurring or expected Doppler shift. If the maximum pulse repetition rate is less than twice the maximum occurring Doppler shift, the Nyquist sampling theorem is in principle violated. However, this violation may be necessary to perform a PWD method in a vascular support system.


According to an advantageous embodiment, it is proposed that the operating parameter is at least one rotational speed, one current, one power, or one pressure. The operating parameter is preferably a rotational speed (or rotation rate) of the flow machine, e.g., of a drive (e.g., of an electric motor) and/or of a paddle wheel of the flow machine. The at least one operating parameter furthermore preferably comprises a rotational speed of the flow machine and a differential pressure across the flow machine.


According to an advantageous embodiment, it is proposed that a plausible range in which plausible measurement results can be located is (a priori) determined using the operating parameter. In this context, a window function or windowing can be used in the frequency analysis (e.g., by means of discrete Fourier transformation) of the (reflected and then) received ultrasonic pulse. A so-called Hamming window is preferably used. The windowing, in particular the Hamming window, can advantageously be formed as a function of the operating parameter and/or the expected and/or estimated flow velocity (on the basis of the operating parameter) and/or the expected and/or estimated fluid volume flow (on the basis of the operating parameter).


According to an advantageous embodiment, it is proposed that a fluid volume flow through the support system is determined using the flow velocity. In other words, this relates in particular to a fluid volume flow which flows (only) through the support system itself, e.g., through an (inlet) tube or an (inlet) cannula of the support system. The fluid volume flow is usually the so-called pump volume flow (Qp), which only quantifies the flow through the support system itself. If this value is known in addition to the total volume flow or heart-time volume (QHZV), the so-called level of support can be calculated from the ratio of Qp to QHZV (i.e., Qp/QHZV). In order to determine the fluid volume flow, the determined flow velocity can be multiplied, for example, with a flow cross section of the support system, in particular a tube or cannula flow cross section.


According to a further aspect, an implantable, vascular support system is, comprising:

    • an ultrasonic sensor configured to carry out a pulsed Doppler measurement,
    • a flow machine,
    • a processing unit configured to correct a possible ambiguity of a measurement result of the ultrasonic sensor using the operating parameter of the flow machine.


The support system is preferably a left ventricular heart support system (LVAD) or a percutaneous, minimally invasive left-heart support system. Furthermore, the support system is preferably fully implantable. In other words, this means in particular that the means required for the detection, in particular the ultrasonic sensor, are completely located in the body of the patient and remain there. The support system can also be designed in multiple parts or with several components that can be arranged at a distance from one another, so that, for example, the ultrasonic sensor and the processing unit (measuring unit) can be separated from one another by a cable. In the multi-part design, the processing unit arranged separately from the ultrasonic sensor can also be implanted or arranged outside the body of the patient. In any case, it is not absolutely necessary for the processing unit to also be arranged in the body of the patient. For example, the support system can be implanted such that the processing unit is arranged on the skin of the patient or outside the body of the patient and a connection is established to the ultrasonic sensor arranged in the body. The support system is particularly preferably configured and/or suitable for being arranged at least partially in a ventricle, preferably in the left ventricle of a heart, and/or in an aorta, in particular in the aortic valve position.


The support system furthermore preferably comprises a tube (or a cannula), in particular an inlet tube or inlet cannula, a flow machine, such as a pump and/or an electric motor. The electric motor is regularly a component of the flow machine. The (inlet) tube or the (inlet) cannula is preferably configured such that in the implanted state, it can guide fluid from a (left) ventricle of a heart to the flow machine. The support system is preferably elongated and/or tubular. The tube (or the cannula) and the flow machine are preferably arranged in the region of opposite ends of the support system.


In particular, precisely or only one ultrasonic sensor is provided. The ultrasonic sensor preferably comprises precisely or only one ultrasound transducer element. This is in particular sufficient for a Doppler measurement if the PWD method is used.


The flow machine is preferably designed at least in the manner of a pump or an (axial or radial) compressor. The flow machine can provide at least one of its (current) operating parameters of the processing unit. In addition, a control unit for controlling or regulating the flow machine can be provided, which, for example, controls or regulates at least one rotational speed or one power of the flow machine as a function of (among other things) a flow velocity determined by way of example by the processing unit.


The support system is preferably configured to carry out a method proposed here.


According to a further aspect, a use of an operating parameter of a flow machine of an implanted vascular support system for correcting a possible ambiguity of a measurement result of an ultrasonic sensor of the support system is proposed. Preferably, at least one method proposed here or a support system proposed here is used for correcting a possible ambiguity of a measurement result of an ultrasonic sensor.


The details, features, and advantageous embodiments discussed in connection with the method can also arise accordingly in the support system presented here and/or in the use and vice versa. In this respect, reference is made in full to the explanations there regarding the detailed characterization of the features.





The solution presented here as well as its technical environment are explained in more detail below with reference to the figures. It should be pointed out that the invention is not to be limited by the exemplary embodiments shown. In particular, unless explicitly stated otherwise, it is also possible to extract partial aspects of the facts explained in the figures and to combine them with other components and/or insights from other figures and/or the present description. The following are shown schematically:


BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 an implantable vascular support system,



FIG. 2 the support system according to FIG. 1 implanted in a heart,



FIG. 3 a further implantable vascular support system,



FIG. 4 the support system according to FIG. 3 implanted in a heart,



FIG. 5 an exemplary illustration of a Doppler measurement,



FIG. 6 a sequence of a method presented here in a normal operating procedure,



FIG. 7 an exemplary Doppler frequency spectrum,



FIG. 8 a further exemplary Doppler frequency spectrum, and



FIG. 9 a functional illustration of a possible embodiment of the method presented here.





DETAILED DESCRIPTION

The vascular support system is preferably a ventricular and/or cardiac support system or a heart support system. Two particularly advantageous forms of heart support systems are systems positioned in the aorta according to FIG. 2 and systems positioned apically according to FIG. 4. The respective systems are explained in more detail in connection with FIG. 1 (aortic) and FIG. 3 (apical).



FIG. 1 schematically shows an implantable vascular support system 1. FIG. 1 illustrates an embodiment of an aortically positioned (cf. FIG. 2) or positionable support system 1. The support system 1 comprises an ultrasonic sensor 2 configured to carry out a pulsed Doppler measurement, a flow machine 3, and a processing unit 6 configured to correct a possible ambiguity of a measurement result of the ultrasonic sensor 2 using the operating parameter of the flow machine 3. The ultrasonic sensor 2 in this case comprises by way of example precisely one ultrasound (transducer) element 19.


In this case, the support system 1 according to FIG. 1 furthermore comprises, by way of example, a distal part with inlet openings 7 through which the blood can be drawn into the interior of the system, and an inlet tube 8 (which is formed in the manner of an inlet cannula in the aortic embodiment according to FIG. 1). In addition, the flow machine 3 is equipped by way of example with an impeller 9. In this case, a supply cable 10 is positioned by way of example proximally to the drive (e.g., electric motor; not shown here) of the flow machine 3. In the region of the impeller 9, there are also outlet openings 11, through which the blood can be discharged. During operation, a fluid volume flow 5 flows through the inlet tube 8, said fluid volume flow entering the support system 1 via the inlet openings 7 and exiting again via the outlet openings 11. This fluid volume flow 5 can also be referred to as a so-called pump volume flow.



FIG. 2 schematically shows the support system 1 according to FIG. 1 implanted in a heart 15. The reference signs are used uniformly so that reference can be made to the above explanations.


The inlet openings 7 are located in the implanted state, for example, in the region of the ventricle 12, while the outlet openings are located in the implanted state in the region of the aorta 13. This orientation of the support system 1 is merely exemplary here and not mandatory; rather, the support system can be oriented in the reverse direction, for example. In this case, the system is furthermore implanted by way of example in such a way that it passes through the aortic valve 14. Such an arrangement can also be referred to as a so-called aortic valve position.



FIG. 3 schematically shows a further implantable vascular support system 1. FIG. 3 illustrates an embodiment of an apically positioned (cf. FIG. 4) or positionable support system 1. The functioning of an apically implanted system is in principle comparable so that uniform reference signs can be used for all components in this case. Reference is therefore made here to the above explanations regarding FIG. 1.



FIG. 4 schematically shows the support system 1 according to FIG. 3 implanted in a heart 15. The reference signs are used uniformly so that reference can also be made here to the above explanations.



FIG. 5 schematically shows an exemplary illustration of a Doppler measurement. For this purpose, the ultrasonic sensor 2 of the support system 1 according to FIG. 1 is used by way of example in order to carry out a measurement in an inlet tube 8 of the support system 1 according to FIG. 1.


The measurement window, also referred to as the observation window and/or measurement range, for the ultrasound measurement is marked in FIGS. 1, 3, and 5 with reference sign 16. The selection of the measurement window 16 depends on the specific design of the (heart) support system 1 and should in principle be positioned where suitable flow conditions prevail. For example, FIG. 5 shows a simplified sectional view of the distal end of the embodiment of FIG. 1. In this case, it is shown schematically that no parallel flow lines prevail to the left of the measurement window 16 in the range 17. Since the Doppler effect is also a function of the cos(α) between the main beam direction of the ultrasound transducer and the main flow direction, it is advantageous to measure in a range of parallel flow lines. Although a measurement window (e.g., range 18) positioned too far away is possible in principle, it can intensify the aliasing effect explained below and/or provide strong attenuation of the ultrasound signal.


The ultrasonic sensor 2 is configured to carry out a pulsed Doppler measurement. The pulsed Doppler (pulsed wave Doppler; in short: PWD) method is basically used for ultrasound measurement in this case. The ultrasonic sensor 2 and the processing unit 6 can therefore also be referred to below as a so-called PWD system.


The measurement window 16 can typically be selected electronically in the PWD system so that a statement about the flow conditions in different regions of the flow guidance can also advantageously be made by means of measurement windows 16 of different depths.


In the (apical) embodiment according to FIG. 4, the blood flows toward the ultrasound element 19 in the opposite direction. The rotating impeller 9 is located between ultrasound element 19 and inlet tube 8. In this case, strong turbulence in the blood flow is to be expected so that it is also particularly advantageous here to position the measurement window 16 in front of the impeller 9, approximately in the region of the inlet tube 8.


The relatively high flow velocities in the range of the measurement window 16 in relation to the distance of the ultrasound (transducer) element 19 from the measurement window 16 have a great influence on the PWD application in both (heart) support system variants, predominantly in the (aortic) variant according to FIG. 1.



FIG. 6 schematically shows a sequence of a method presented here in a normal operating procedure. The method is used to determine at least a flow velocity or a fluid volume flow of a fluid flowing through an implanted vascular support system 1 (cf. FIGS. 1 to 5). The illustrated order of the method steps a), b), c), and d) with the blocks 110, 120, 130, and 140 is only exemplary. In block 110, a pulsed Doppler measurement is carried out by means of an ultrasonic sensor 2 of the support system 1. In block 120, a measurement result from step a) which has a possible ambiguity is evaluated. In block 130, at least one operating parameter of a flow machine 3 of the support system 1 is provided. In block 140, at least the flow velocity or the fluid volume flow is determined using the measurement result evaluated in step b). In the method, the possible ambiguity of the measurement result is corrected using the operating parameter.


For an exemplary illustration of the method, a system according to FIG. 1 with the following parameters is assumed:

    • inner diameter of the inlet tube: 5 mm
    • maximum blood flow to be measured: 9 liters/minute
    • resulting maximum flow velocity: 7.64 meters/second
    • sound speed in blood: 1540 m/s
    • frequency of ultrasound: 6 MHz
    • distance of the ultrasound transducer from the start of the measurement window: 25 mm
    • ultrasound oscillation cycles per sent-out ultrasonic PVD pulse: 10
    • resulting burst length (10 oscillations at 1540 m/s): 2.57 mm


An ultrasonic pulse is sent out at the ultrasound element 19 and propagates in the direction of the measurement window 16. After sending out the pulse, the PWD system switches to the receiving direction and receives the portions that are continuously scattered back by scattering bodies in the blood, for example. The transit time of the pulse from the ultrasound element to the measurement window and from the measurement window back to the ultrasound element is taken into account in the process. In the case shown, the total relevant propagation path is thus 55.13 mm long (ultrasound element 19 to start of measurement window 16 plus burst length×2). The PWD system is switched back to transmission mode and the next pulse is sent out at the earliest when the last echo from the range of the measurement window 16 has arrived. In the specifically considered case, the pulse transit time limits the maximum pulse repetition rate to 27.93 kHz.


On the other hand, the maximum Doppler shift occurring in the case shown is 59.53 kHz. In a complex-value evaluation (10 demodulation), this leads to a minimum pulse repetition rate of 59.53 kHz, in which the present Doppler shift can be interpreted without ambiguity. However, since the measurement is carried out with a maximum of 27.93 kHz (maximum pulse repetition rate; see above), the Nyquist sampling theorem is violated in this case and ambiguities generally occur in the resulting Doppler spectrum. In this case, these ambiguities are resolved using an operating parameter of the flow machine of the support system in order to be able to make a clear statement about the main flow velocity in the observation window.



FIG. 7 schematically shows an exemplary Doppler frequency spectrum. Here, a schematic illustration of the previously presented relationships in the frequency spectrum is shown. A corresponding illustration of the shown relationships is also illustrated in FIG. 8.



FIG. 7 shows the amplitude 32 of the Doppler signal over the (averaged) frequency 33 with fixed pulse repetition rate 34 (PRF). The (fixed) pulse repetition rate 34 in the example considered here is 27 kHz. Simplified spectra for various flow velocities of the fluid (here: the blood) are shown in FIG. 7. A first flow velocity 20 is less than a second flow velocity 21, which in turn is less than a third flow velocity 22, which in turn is less than a fourth flow velocity 23, which in turn is less than a fifth flow velocity 24.


It can be seen that at the third flow velocity 22, there is already a violation of the Nyquist theorem, i.e., the Doppler frequency is in the range of the pulse repetition rate (PRF; here 27 kHz by way of example). With further increasing flow velocity of the blood, the spectrum moves from the negative frequency range to the coordinate origin. Here, there is already ambiguity about the direction of flow, i.e., either a fast flow toward the ultrasound element or a slower flow away from the ultrasound element. With further increasing flow velocity, the spectrum of the fifth flow velocity 24 appears in the ambiguity range of high or low flow velocity.


The solution presented here advantageously allows a resolution of such ambiguities. In principle, a comparatively rough range estimation can contribute to this purpose since the ultrasound method still works with high precision (resolution to 1-2 decimal places of the flow velocity in meters/second or of the volume flow in liters/minute), but ambiguity about the range of several meters/second or liters/minute is present.



FIG. 8 schematically shows another exemplary Doppler frequency spectrum. FIG. 8 illustrates the problem and the resolution of ambiguity once again using the example with the parameters used above fus=6 MHz, PRF=27.93 kHz, Cblood=1540 m/s, and a windowing (window function) with a so-called Hamming window 25. The figure shows the frequency behavior at the following flow velocities:

    • first flow velocity 20=−1 m/s,
    • second flow velocity 21=+1 m/s,
    • third flow velocity 22=2 m/s,
    • fourth flow velocity 23=3 m/s,
    • fifth flow velocity 24=4.5 m/s.


In this context, a negative velocity means blood flowing toward the ultrasound element and appears in a frequency shift with a positive sign.


This example shows that the measured frequency peaks are very close to one another at flow velocities of 1 m/s and 4.5 m/s. This ambiguity can be resolved by the (a priori) knowledge of the approximate velocity on the basis of the operating parameter of the flow machine.


This approximate velocity interval vint (plausible range of the flow velocity) can be resolved with the aid of the following formula to a corresponding Doppler shift or a Doppler shift interval fd.int.







f

d
,
int


=



2
·

f
0



c
Blut


·

v
int






In the example, the corresponding Doppler shift interval is 31.95 kHz to 35.84 kHz. In order to shift the corresponding frequency interval into the frequency range that can be represented with the PRF used, the determined non-representable frequencies can be converted into the representable frequency range using the following formula (for positive flow velocities).







f

d
,
int
,

P





R





F



=


(


f

d
,
int



mod





P





R





F

)

-


P





R





F

2






For the values shown in the example, the frequency interval that can be predicted by means of the operating parameter thus includes all frequencies between −9.95 kHz and −6.05 kHz. All frequencies measured in this interval correspond to velocities in the range of 4.1 m/s to 4.6 m/s.


The exact velocity (actual flow velocity) can be determined by a calculation from the number of spectral “wraps” with the aid of the operating parameter interval (frequency interval that can be predicted by means of the operating parameter) and successive back calculation from the measured frequency using the formulas already shown. A “wrap” here refers to the jump of a signal from the greatest positive representable frequency (fpRF/2) to the representable negative frequency of highest magnitude (−fpRF/2). The true frequency is determined according to the formula

fd=nfPRF=fmeas

    • where the parameter n denotes the number of spectral “wraps.” For low flow velocities, fd=fmeas; at higher velocities, ambiguities occur with regard to the value of n, which can be resolved according to the solution proposed here by additional knowledge (the operating parameter(s) of the flow machine).



FIG. 9 schematically shows a functional illustration of a possible embodiment of the method presented here. The method in accordance with the illustration according to FIG. 9 serves to resolve the ambiguities. A PWD volume flow measurement 26 and a motor characteristic map-based volume flow measurement 27 take place in parallel or sequentially. The PWD volume flow measurement 26 can, for example, be carried out during step a). The motor characteristic map-based volume flow measurement 27 can be carried out, for example, between steps c) and d) or during step d). The PWD volume flow measurement 26 provides a Doppler spectrum 28. This can occur during step b), for example. The motor characteristic map-based volume flow measurement 27 provides an estimated (rough) fluid volume flow 4. This can occur, for example, between steps c) and d) or during step d). The Doppler spectrum 28 and the estimated fluid volume flow 4 are sent to an anti-aliasing unit 29. The anti-aliasing unit 29 determines from the estimated fluid volume flow 4 the (plausible) range in which the (actual) flow velocity is located, and from the Doppler spectrum 28 and the (plausible) volume flow range the corrected flow velocity 30, which is here also referred to as (actual) flow velocity through the support system. The anti-aliasing unit 29 can, for example, be a component of the processing unit also described here. A volume flow calculation unit 31 combines the known cross-sectional geometry and the known flow profiles determined in a construction type-specific and flow velocity-dependent manner for the (actual) fluid volume flow 5.


The PWD volume flow measurement 26 can comprise the following steps:

    • sending out an ultrasonic pulse,
    • waiting until the relevant echo of the measurement window,
    • receiving the echo of the measurement window,
    • possibly waiting for another waiting period until distant echoes die away,
    • sending out the next ultrasonic pulse.


The generated data can be stored temporarily in a memory for later evaluation or (e.g., with parallel implementation in programmable logic) can be further processed directly. While the ultrasonic pulse from the desired measurement window arrives (time limitation), the received echo sequence with the known ultrasonic pulse frequency is generally demodulated (“downmixing into the baseband”). Subsequently, the obtained baseband signal is generally transformed into the frequency range (transformation from time to frequency range for calculating the Doppler spectrum).


The motor characteristic map-based volume flow measurement 27 (rough volume flow measurement) can comprise the following steps:

    • determining a pump operating parameter, such as rotation rate (revolutions per minute, in short: RPM), power consumption, current consumption, and/or pressure difference across the flow machine (e.g., pump),
    • calculating the estimated fluid volume flow via a relationship determined in a type-specific manner or via interpolation (e.g., table-based interpolation) from a motor characteristic map determined in a type-specific manner.


The volume flow calculation unit 31, for example, carries out the following: multiplication of the known cross section in the range of the observation window 16 (formula symbol: A) with the flow velocity 30 (formula symbol: v), and a flow velocity-dependent flow profile correction parameter (formula symbol f(v)). In this case, the (actual) fluid volume flow (formula symbol Qp) can result according to the following formula:

Qp=f(vv×A


The anti-aliasing unit 29 and the volume flow calculation unit 31 can also be combined into one unit. In addition, the Doppler spectrum can be mapped directly to the volume flow Qp, for example.


The solution presented here allows in particular one or more of the following advantages:

    • highly accurate calculation of the pump volume flow by means of a Doppler ultrasonic sensor.
    • combination of a high-precision Doppler ultrasound measurement and a rough estimation on the basis of motor operating parameters (e.g., one or more of rotational speed, current, power, built-up pressure) allows the operation of the ultrasound measurement with violation of the Nyquist theorem (necessity arising from geometric conditions) and a subsequent resolution of arisen ambiguities with the aid of the rough estimate.

Claims
  • 1. A method for determining a flow velocity of blood flowing through a cardiac support system, the method comprising: carrying out a pulsed Doppler measurement of blood flowing through the cardiac support system using an ultrasonic sensor of the cardiac support system to determine a measurement result, the cardiac support system further comprising: a flow machine; anda processing unit configured to correct a possible ambiguity of the measurement result of the ultrasonic sensor based on at least one operating parameter of the flow machine to determine at least the blood flow velocity or the blood volume flow;evaluating the measurement result to generate an evaluated measurement result, wherein the measurement result comprises the possible ambiguity;determining the at least one operating parameter of the flow machine of the cardiac support system;determining the blood flow velocity or the blood volume flow based on the evaluated measurement result; andcorrecting the possible ambiguity of the measurement result using the at least one operating parameter.
  • 2. The method of claim 1, wherein carrying out the pulse Doppler measurement comprises emitting a second ultrasonic pulse after an echo of a prior first ultrasonic pulse has died away.
  • 3. The method of claim 1, wherein evaluating the measurement result comprises determining that the pulsed Doppler measurement has a pulse repetition rate of less than two times a maximum Doppler frequency shift of the blood flowing through the cardiac support system.
  • 4. The method of claim 1, wherein the at least one operating parameter is based on at least one of the following: a rotational speed of a drive of the flow machine, an electrical current of the flow machine, an electrical power of the flow machine, and a differential pressure across the flow machine.
  • 5. The method of claim 4, wherein determining the flow velocity is further based on the at least one operating parameter.
  • 6. The method of claim 1, further comprising determining a plausible range in which plausible measurement results can be located based on the at least one operating parameter.
  • 7. The method of claim 1, further comprising determining a fluid volume flow of the blood flowing through the cardiac support system based on the flow velocity.
  • 8. The method of claim 1, wherein the at least one possible ambiguity comprises several possible flow velocities of the flowing blood.
  • 9. A cardiac support system comprising: a flow machine;an ultrasonic sensor configured to carry out a pulsed Doppler measurement of blood flowing through the cardiac support system; anda processing unit configured to correct a possible ambiguity of a measurement result of the ultrasonic sensor based on at least one operating parameter of the flow machine to determine at least the blood flow velocity or the blood volume flow.
  • 10. The support system of claim 9, wherein, to correct the possible ambiguity, the processing unit is further configured to: cause the ultrasonic sensor to carry out a pulsed Doppler measurement using an ultrasonic sensor of the cardiac support system to determine the measurement result;determine the at least one operating parameter of the flow machine of the cardiac support system; anddetermine at least the blood flow velocity or the blood volume flow based on the measurement result, wherein the possible ambiguity of the measurement result is corrected using the operating parameter.
  • 11. The cardiac support system of claim 9, wherein the ultrasonic sensor is further configured to carry out the pulsed Doppler measurement by emitting a new ultrasonic pulse only if an echo of an ultrasonic pulse sent out immediately beforehand has died away.
  • 12. The cardiac support system of claim 9, wherein the measurement result comprises the possible ambiguity based on the pulsed Doppler measurement having a maximum pulse repetition rate of less than two times a maximum occurring Doppler shift of the flowing blood.
  • 13. The cardiac support system of claim 9, wherein the at least one operating parameter comprises at least one of the following: a rotational speed of a drive of the flow machine, an electrical current consumption of the flow machine, an electrical power consumption of the flow machine, and a differential pressure across the flow machine, a derived parameter of the rotational speed of a drive of the flow machine, a derived parameter of the electrical current consumption of the flow machine, a derived parameter of the electrical power consumption of the flow machine, and a derived parameter of the differential pressure across the flow machine.
  • 14. The cardiac support system of claim 13, wherein to determining at least the flow velocity or the fluid volume flow is further based on the at least one operating parameter.
  • 15. The cardiac support system of claim 9, wherein to determine at least the blood flow velocity or the blood volume flow, the processing unit is configured to determine a plausible range in which plausible measurement results can be located based on the at least one operating parameter.
  • 16. The cardiac support system of claim 9, wherein the blood volume flow through the cardiac support system is determined based on the blood flow velocity.
Priority Claims (1)
Number Date Country Kind
102018208933.7 Jun 2018 DE national
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2019/064807 6/6/2019 WO
Publishing Document Publishing Date Country Kind
WO2019/234166 12/12/2019 WO A
US Referenced Citations (522)
Number Name Date Kind
3088323 Welkowitz et al. May 1963 A
4023562 Hynecek et al. May 1977 A
4559952 Angelsen et al. Dec 1985 A
4680730 Omoda Jul 1987 A
4781525 Hubbard et al. Nov 1988 A
4888011 Kung et al. Dec 1989 A
4889131 Salem et al. Dec 1989 A
4902272 Milder et al. Feb 1990 A
5045051 Milder et al. Sep 1991 A
5269811 Hayes Dec 1993 A
5289821 Swartz Mar 1994 A
5456715 Liotta Oct 1995 A
5527159 Bozeman, Jr. et al. Jun 1996 A
5581038 Lampropoulos Dec 1996 A
5613935 Jarvik Mar 1997 A
5662115 Torp Sep 1997 A
5676651 Larson, Jr. et al. Oct 1997 A
5720771 Snell Feb 1998 A
5752976 Duffin et al. May 1998 A
5766207 Potter et al. Jun 1998 A
5827203 Nita Oct 1998 A
5865759 Koblanski Feb 1999 A
5888242 Antaki et al. Mar 1999 A
5904708 Goedeke May 1999 A
5911685 Siess et al. Jun 1999 A
5964694 Siess et al. Oct 1999 A
5980465 Elgas Nov 1999 A
6007478 Siess et al. Dec 1999 A
6024704 Meador et al. Feb 2000 A
6053873 Govari et al. Apr 2000 A
6167765 Weitzel Jan 2001 B1
6176822 Nix et al. Jan 2001 B1
6183412 Benkowsi et al. Feb 2001 B1
6185460 Thompson Feb 2001 B1
6190324 Kieval et al. Feb 2001 B1
6210318 Lederman Apr 2001 B1
6231498 Pfeiffer et al. May 2001 B1
6245007 Bedingham et al. Jun 2001 B1
6314322 Rosenberg Nov 2001 B1
6351048 Schob et al. Feb 2002 B1
6398734 Cimochowski et al. Jun 2002 B1
6432136 Weiss et al. Aug 2002 B1
6438409 Malik et al. Aug 2002 B1
6512949 Combs et al. Jan 2003 B1
6530876 Spence Mar 2003 B1
6540658 Fasciano et al. Apr 2003 B1
6540659 Milbocker Apr 2003 B1
6561975 Pool et al. May 2003 B1
6579257 Elgas et al. Jun 2003 B1
6602182 Milbocker Aug 2003 B1
6605032 Benkowsi et al. Aug 2003 B2
6652447 Benkowsi et al. Nov 2003 B2
6731976 Penn et al. May 2004 B2
6879126 Paden et al. Apr 2005 B2
6912423 Ley et al. Jun 2005 B2
6949066 Bearnson et al. Sep 2005 B2
6984201 Khaghani et al. Jan 2006 B2
7010954 Siess Mar 2006 B2
7022100 Aboul-Hosn et al. Apr 2006 B1
7024244 Muhlenberg et al. Apr 2006 B2
7070555 Siess Jul 2006 B2
7083588 Shmulewitz et al. Aug 2006 B1
7138776 Gauthier et al. Nov 2006 B1
7160243 Medvedev Jan 2007 B2
7175588 Morello Feb 2007 B2
7177681 Xhu Feb 2007 B2
7238151 Frazier Jul 2007 B2
7396327 Morello Jul 2008 B2
7513864 Kantrowitz et al. Apr 2009 B2
7520850 Brockway Apr 2009 B2
7527599 Hickey May 2009 B2
7591777 LaRose Sep 2009 B2
7744560 Struble Jun 2010 B2
7794384 Sugiura et al. Sep 2010 B2
7819916 Yaegashi Oct 2010 B2
7850593 Vincent et al. Dec 2010 B2
7850594 Sutton et al. Dec 2010 B2
7856335 Morello et al. Dec 2010 B2
7862501 Woodward et al. Jan 2011 B2
7951062 Morello May 2011 B2
7951129 Chinchoy May 2011 B2
7963905 Salmonsen et al. Jun 2011 B2
7988728 Ayre Aug 2011 B2
8075472 Zilbershlag et al. Dec 2011 B2
8190390 Morello et al. May 2012 B2
8211028 Karamanoglu et al. Jul 2012 B2
8303482 Schima et al. Nov 2012 B2
8323173 Benkowsi et al. Dec 2012 B2
8435182 Tamura May 2013 B1
8449444 Poirier May 2013 B2
8545380 Farnan et al. Oct 2013 B2
8585572 Mehmanesh Nov 2013 B2
8591393 Walters et al. Nov 2013 B2
8594790 Kjellstrom et al. Nov 2013 B2
8622949 Zafirelis et al. Jan 2014 B2
8657733 Ayre et al. Feb 2014 B2
8657875 Kung et al. Feb 2014 B2
8715151 Poirier May 2014 B2
8747293 Arndt et al. Jun 2014 B2
8849398 Evans Sep 2014 B2
8864643 Reichenbach et al. Oct 2014 B2
8864644 Yomtov Oct 2014 B2
8876685 Crosby et al. Nov 2014 B2
8882477 Fritz, IV et al. Nov 2014 B2
8888728 Aboul-Hosn et al. Nov 2014 B2
8897873 Schima et al. Nov 2014 B2
8903492 Soykan et al. Dec 2014 B2
9091271 Bourque Jul 2015 B2
9297735 Graichen et al. Mar 2016 B2
9308305 Chen et al. Apr 2016 B2
9345824 Mohl et al. May 2016 B2
9371826 Yanai et al. Jun 2016 B2
9427508 Reyes et al. Aug 2016 B2
9474840 Siess Oct 2016 B2
9492601 Casas et al. Nov 2016 B2
9511179 Casas et al. Dec 2016 B2
9555173 Spanier Jan 2017 B2
9555175 Bulent et al. Jan 2017 B2
9556873 Yanai et al. Jan 2017 B2
9566374 Spence et al. Feb 2017 B2
9636442 Karmon et al. May 2017 B2
9656010 Burke May 2017 B2
9669142 Spanier et al. Jun 2017 B2
9669144 Spanier et al. Jun 2017 B2
9694123 Bourque et al. Jul 2017 B2
9713701 Sarkar et al. Jul 2017 B2
9744282 Rosenberg et al. Aug 2017 B2
9789236 Bonde Oct 2017 B2
9833550 Siess Dec 2017 B2
9848899 Sliwa et al. Dec 2017 B2
9849224 Angwin et al. Dec 2017 B2
9878087 Richardson et al. Jan 2018 B2
9943236 Bennett et al. Apr 2018 B2
9950102 Spence et al. Apr 2018 B2
9974894 Morello May 2018 B2
9999714 Spanier et al. Jun 2018 B2
10010662 Wiesener et al. Jul 2018 B2
10022480 Greatrex et al. Jul 2018 B2
10029037 Muller et al. Jul 2018 B2
10052420 Medvedev et al. Aug 2018 B2
10279093 Reichenbach et al. May 2019 B2
10322217 Spence Jun 2019 B2
10342906 D'Ambrosio et al. Jul 2019 B2
10350342 Thomas et al. Jul 2019 B2
10357598 Aboul-Hosn et al. Jul 2019 B2
10376162 Edelman et al. Aug 2019 B2
10413651 Yomtov et al. Sep 2019 B2
10426879 Farnan Oct 2019 B2
10449275 Corbett Oct 2019 B2
10500322 Karch Dec 2019 B2
10525178 Zeng Jan 2020 B2
10549020 Spence et al. Feb 2020 B2
10561771 Heilman et al. Feb 2020 B2
10561772 Schumacher Feb 2020 B2
10561773 Ferrari et al. Feb 2020 B2
10632241 Schenck et al. Apr 2020 B2
10660998 Hodges May 2020 B2
10668195 Flores Jun 2020 B2
10732583 Rudser Aug 2020 B2
10857275 Granegger Dec 2020 B2
10864308 Muller et al. Dec 2020 B2
11027114 D'Ambrosio et al. Jun 2021 B2
RE48649 Siess Jul 2021 E
11067085 Granegger et al. Jul 2021 B2
11120908 Agnello et al. Sep 2021 B2
11131968 Rudser Sep 2021 B2
11147960 Spanier et al. Oct 2021 B2
11154701 Reyes et al. Oct 2021 B2
11154702 Kadrolkar et al. Oct 2021 B2
11185682 Farnan Nov 2021 B2
11191945 Siess et al. Dec 2021 B2
11197618 Edelman et al. Dec 2021 B2
11217344 Agnello Jan 2022 B2
11235139 Kudlik Feb 2022 B2
11241572 Dague et al. Feb 2022 B2
11273299 Wolman et al. Mar 2022 B2
11285310 Curran et al. Mar 2022 B2
11285311 Siess et al. Mar 2022 B2
11298524 El Katerji et al. Apr 2022 B2
11311711 Casas et al. Apr 2022 B2
11316679 Agnello Apr 2022 B2
11320382 Aikawa May 2022 B2
11324395 Banik et al. May 2022 B2
11331082 Itoh et al. May 2022 B2
11337724 Masubuchi et al. May 2022 B2
11338125 Liu et al. May 2022 B2
11351356 Mohl Jun 2022 B2
11351357 Mohl Jun 2022 B2
11351358 Nix et al. Jun 2022 B2
11357438 Stewart et al. Jun 2022 B2
11357968 El Katerji et al. Jun 2022 B2
11376415 Mohl Jul 2022 B2
11376419 Reyes et al. Jul 2022 B2
11389639 Casas Jul 2022 B2
11389641 Nguyen et al. Jul 2022 B2
11413444 Nix et al. Aug 2022 B2
11413445 Brown et al. Aug 2022 B2
11420041 Karch Aug 2022 B2
11439806 Kimball et al. Sep 2022 B2
11446481 Wolman et al. Sep 2022 B2
11478629 Harjes et al. Oct 2022 B2
11517740 Agarwa et al. Dec 2022 B2
11521723 Liu et al. Dec 2022 B2
11524165 Tan et al. Dec 2022 B2
11527322 Agnello et al. Dec 2022 B2
11529062 Moyer et al. Dec 2022 B2
11554260 Reyes et al. Jan 2023 B2
11572879 Mohl Feb 2023 B2
11574741 Tan et al. Feb 2023 B2
11577068 Spence et al. Feb 2023 B2
11581083 El Katerji et al. Feb 2023 B2
11583659 Pfeffer et al. Feb 2023 B2
11587337 Lemay et al. Feb 2023 B2
11590337 Granegger et al. Feb 2023 B2
11622695 Adriola et al. Apr 2023 B1
11628293 Gandhi et al. Apr 2023 B2
11639722 Medvedev et al. May 2023 B2
11648386 Poirer May 2023 B2
11653841 Reyes et al. May 2023 B2
11666746 Ferrari et al. Jun 2023 B2
11668321 Richert et al. Jun 2023 B2
11674517 Mohl Jun 2023 B2
11676718 Agnello et al. Jun 2023 B2
11684276 Cros et al. Jun 2023 B2
11684769 Harjes et al. Jun 2023 B2
11694539 Kudlik et al. Jul 2023 B2
11694813 El Katerji et al. Jul 2023 B2
11696782 Carlson et al. Jul 2023 B2
11707617 Reyes et al. Jul 2023 B2
11712167 Medvedev et al. Aug 2023 B2
11754077 Mohl Sep 2023 B1
D1001145 Lussier et al. Oct 2023 S
D1001146 Lussier et al. Oct 2023 S
11771885 Liu et al. Oct 2023 B2
11779234 Harjes et al. Oct 2023 B2
11781551 Yanai et al. Oct 2023 B2
11790487 Barbato et al. Oct 2023 B2
11793994 Josephy et al. Oct 2023 B2
11806116 Tuval et al. Nov 2023 B2
11806517 Petersen Nov 2023 B2
11806518 Michelena et al. Nov 2023 B2
11813079 Lau et al. Nov 2023 B2
11818782 Doudian et al. Nov 2023 B2
11824381 Conyers et al. Nov 2023 B2
11826127 Casas Nov 2023 B2
11832793 McWeeney et al. Dec 2023 B2
11832868 Smail et al. Dec 2023 B2
11837364 Lee et al. Dec 2023 B2
11844592 Tuval et al. Dec 2023 B2
11844940 D'Ambrosio et al. Dec 2023 B2
11850073 Wright et al. Dec 2023 B2
11850414 Schenck et al. Dec 2023 B2
11850415 Schwammenthal et al. Dec 2023 B2
D1012284 Glaser et al. Jan 2024 S
11857345 Hanson et al. Jan 2024 B2
11864878 Duval et al. Jan 2024 B2
11872384 Cotter Jan 2024 B2
11883207 El Katerji et al. Jan 2024 B2
D1014552 Lussier et al. Feb 2024 S
11890082 Cros et al. Feb 2024 B2
11896199 Lent et al. Feb 2024 B2
11900660 Saito et al. Feb 2024 B2
11903657 Geric et al. Feb 2024 B2
11906411 Graichen et al. Feb 2024 B2
11911550 Itamochi et al. Feb 2024 B2
D1017634 Lussier et al. Mar 2024 S
D1017699 Moore et al. Mar 2024 S
11923078 Fallen et al. Mar 2024 B2
11923093 Moffitt et al. Mar 2024 B2
11925794 Malkin et al. Mar 2024 B2
11931073 Walsh et al. Mar 2024 B2
11931528 Rohl et al. Mar 2024 B2
11931588 Aghassian Mar 2024 B2
11986274 Edelman May 2024 B2
12017076 Tan et al. Jun 2024 B2
12023476 Tuval et al. Jul 2024 B2
12029891 Siess et al. Jul 2024 B2
12059559 Muller et al. Aug 2024 B2
D1043730 Lussier et al. Sep 2024 S
D1043731 Lussier et al. Sep 2024 S
12076544 Siess et al. Sep 2024 B2
12097016 Goldvasser Sep 2024 B2
12102815 Dhaliwal et al. Oct 2024 B2
12144650 Spanier et al. Nov 2024 B2
12144976 Baumbach et al. Nov 2024 B2
20010016686 Okada et al. Aug 2001 A1
20010037093 Benkowski et al. Nov 2001 A1
20010039828 Shin et al. Nov 2001 A1
20020022785 Romano Feb 2002 A1
20020082585 Carroll et al. Jun 2002 A1
20020147495 Petroff Oct 2002 A1
20020151761 Viole et al. Oct 2002 A1
20030069465 Benkowski et al. Apr 2003 A1
20030130581 Salo et al. Jul 2003 A1
20030139643 Smith et al. Jul 2003 A1
20030167002 Nagar et al. Sep 2003 A1
20030191357 Frazier Oct 2003 A1
20030199727 Burke Oct 2003 A1
20040022640 Siess et al. Feb 2004 A1
20040044266 Siess et al. Mar 2004 A1
20040065143 Husher Apr 2004 A1
20040130009 Tangpuz Jul 2004 A1
20040167376 Peters et al. Aug 2004 A1
20040167410 Hettrick Aug 2004 A1
20040225177 Coleman et al. Nov 2004 A1
20040241019 Goldowsky Dec 2004 A1
20040260346 Overall et al. Dec 2004 A1
20050001324 Dunn Jan 2005 A1
20050019167 Nusser et al. Jan 2005 A1
20050107658 Brockway May 2005 A1
20050126268 Ouriev et al. Jun 2005 A1
20050267322 LaRose Dec 2005 A1
20060030809 Barzilay et al. Feb 2006 A1
20060108697 Wang May 2006 A1
20060108901 Mao-Chin May 2006 A1
20060122583 Pesach et al. Jun 2006 A1
20060196277 Allen et al. Sep 2006 A1
20060229488 Ayre et al. Oct 2006 A1
20060287600 McEowen Dec 2006 A1
20060287604 Hickey Dec 2006 A1
20070060787 Peters et al. Mar 2007 A1
20070069354 Dangelmaier Mar 2007 A1
20070073352 Euler et al. Mar 2007 A1
20070088214 Shuros et al. Apr 2007 A1
20070156006 Smith et al. Jul 2007 A1
20070255352 Roline et al. Nov 2007 A1
20070266778 Corey et al. Nov 2007 A1
20070282209 Lui et al. Dec 2007 A1
20070299325 Farrell et al. Dec 2007 A1
20080015517 Geistert et al. Jan 2008 A1
20080082005 Stern et al. Apr 2008 A1
20080091239 Johansson et al. Apr 2008 A1
20080097595 Gabbay Apr 2008 A1
20080102096 Molin et al. May 2008 A1
20080108901 Baba et al. May 2008 A1
20080108930 Weitzel et al. May 2008 A1
20080133006 Crosby et al. Jun 2008 A1
20080146996 Smisson Jun 2008 A1
20080210016 Zwirn et al. Sep 2008 A1
20080262289 Goldowsky Oct 2008 A1
20080262361 Gutfinger et al. Oct 2008 A1
20080269822 Ljungstrom et al. Oct 2008 A1
20080275339 Thiemann et al. Nov 2008 A1
20080306328 Ercolani Dec 2008 A1
20090024042 Nunez et al. Jan 2009 A1
20090025459 Zhang et al. Jan 2009 A1
20090064755 Fleischli et al. Mar 2009 A1
20090105799 Hekmat et al. Apr 2009 A1
20090131765 Roschak et al. May 2009 A1
20090204163 Shuros et al. Aug 2009 A1
20090226328 Morello Sep 2009 A1
20090312650 Maile et al. Dec 2009 A1
20100010354 Skerl et al. Jan 2010 A1
20100082099 Vodermayer et al. Apr 2010 A1
20100087742 Bishop et al. Apr 2010 A1
20100160801 Takatani et al. Jun 2010 A1
20100219967 Kaufmann Sep 2010 A1
20100222632 Poirier Sep 2010 A1
20100222633 Poirier Sep 2010 A1
20100222635 Poirier Sep 2010 A1
20100222878 Poirier Sep 2010 A1
20100268017 Siess Oct 2010 A1
20100298625 Reichenbach et al. Nov 2010 A1
20100324378 Tran et al. Dec 2010 A1
20110004075 Stahmann et al. Jan 2011 A1
20110022057 Eigler et al. Jan 2011 A1
20110071336 Yomtov Mar 2011 A1
20110144744 Wampler Jun 2011 A1
20110172505 Kim Jul 2011 A1
20110184301 Holmstrom Jul 2011 A1
20110218435 Srinivasan et al. Sep 2011 A1
20110230068 Pahl Sep 2011 A1
20120022645 Burke Jan 2012 A1
20120084024 Norcross, Jr. Apr 2012 A1
20120150089 Penka et al. Jun 2012 A1
20120203476 Dam Aug 2012 A1
20120245404 Smith Sep 2012 A1
20120247200 Ahonen et al. Oct 2012 A1
20120310037 Choi et al. Dec 2012 A1
20120330214 Peters et al. Dec 2012 A1
20130041204 Heilman et al. Feb 2013 A1
20130046129 Medvedev et al. Feb 2013 A1
20130066141 Doerr et al. Mar 2013 A1
20130072846 Heide et al. Mar 2013 A1
20130116575 Mickle et al. May 2013 A1
20130144379 Najafi et al. Jun 2013 A1
20130289334 Badstibner Oct 2013 A1
20130289376 Lang Oct 2013 A1
20130303831 Evans Nov 2013 A1
20130304404 Dam Nov 2013 A1
20140005467 Farnan et al. Jan 2014 A1
20140013852 Brown et al. Jan 2014 A1
20140030122 Ozaki Jan 2014 A1
20140100414 Tamez et al. Apr 2014 A1
20140114202 Hein et al. Apr 2014 A1
20140128659 Heuring et al. May 2014 A1
20140200389 Yanai et al. Jul 2014 A1
20140243688 Caron et al. Aug 2014 A1
20140275720 Ferrari Sep 2014 A1
20140275727 Bonde Sep 2014 A1
20140296677 McEowen Oct 2014 A1
20140303426 Kerkhoffs et al. Oct 2014 A1
20140342203 Elian Nov 2014 A1
20150032007 Ottevanger et al. Jan 2015 A1
20150141832 Yu et al. May 2015 A1
20150141842 Spanier et al. May 2015 A1
20150157216 Stigall et al. Jun 2015 A1
20150174307 Eckman et al. Jun 2015 A1
20150190092 Mori Jul 2015 A1
20150250935 Anderson et al. Sep 2015 A1
20150273184 Scott et al. Oct 2015 A1
20150290372 Muller et al. Oct 2015 A1
20150306290 Rosenberg et al. Oct 2015 A1
20150306291 Bonde et al. Oct 2015 A1
20150307344 Ernst Oct 2015 A1
20150327921 Govari Nov 2015 A1
20150335804 Marseille et al. Nov 2015 A1
20150365738 Purvis et al. Dec 2015 A1
20160000983 Mohl et al. Jan 2016 A1
20160008531 Wang et al. Jan 2016 A1
20160022889 Bluvshtein et al. Jan 2016 A1
20160022890 Schwammenthal et al. Jan 2016 A1
20160045165 Braido et al. Feb 2016 A1
20160095968 Rudser Apr 2016 A1
20160101230 Ochsner et al. Apr 2016 A1
20160144166 Decré et al. May 2016 A1
20160151553 Bonde Jun 2016 A1
20160166747 Frazier et al. Jun 2016 A1
20160213828 Sievers Jul 2016 A1
20160250399 Tiller et al. Sep 2016 A1
20160278856 Panescu Sep 2016 A1
20160302672 Kuri Oct 2016 A1
20160317043 Campo Nov 2016 A1
20160338629 Doerr Nov 2016 A1
20170010144 Lenner et al. Jan 2017 A1
20170021070 Petersen Jan 2017 A1
20170049945 Halvorsen et al. Feb 2017 A1
20170086780 Sokulin et al. Mar 2017 A1
20170098491 Ziaie et al. Apr 2017 A1
20170112985 Yomtov Apr 2017 A1
20170128646 Karch May 2017 A1
20170136164 Yeatts May 2017 A1
20170202575 Stanfield et al. Jul 2017 A1
20170224279 Cahan et al. Aug 2017 A1
20170239407 Hayward Aug 2017 A1
20170258980 Katsuki et al. Sep 2017 A1
20170348470 D'Ambrosio et al. Dec 2017 A1
20170354812 Callaghan et al. Dec 2017 A1
20180064860 Nunez et al. Mar 2018 A1
20180078159 Edelman et al. Mar 2018 A1
20180093070 Cottone Apr 2018 A1
20180110910 Rodemerk et al. Apr 2018 A1
20180199635 Longinotti-Buitoni et al. Jul 2018 A1
20180250457 Morello et al. Sep 2018 A1
20180256796 Hansen Sep 2018 A1
20180256800 Conyers et al. Sep 2018 A1
20180264182 Spanier et al. Sep 2018 A1
20180280598 Curran et al. Oct 2018 A1
20180316209 Gliner Nov 2018 A1
20180326131 Muller et al. Nov 2018 A1
20180333059 Casas Nov 2018 A1
20180353667 Moyer et al. Dec 2018 A1
20180369469 Le Duc De Lillers et al. Dec 2018 A1
20190001038 Yomtov et al. Jan 2019 A1
20190054223 Frazier et al. Feb 2019 A1
20190083690 Siess et al. Mar 2019 A1
20190192752 Tiller et al. Jun 2019 A1
20190192753 Liu et al. Jun 2019 A1
20190209755 Nix et al. Jul 2019 A1
20190209758 Tuval et al. Jul 2019 A1
20190216995 Kapur et al. Jul 2019 A1
20190217002 Urakabe Jul 2019 A1
20190223877 Nitzen et al. Jul 2019 A1
20190240680 Hayakawa Aug 2019 A1
20190254543 Hartholt et al. Aug 2019 A1
20190282741 Franano et al. Sep 2019 A1
20190282744 D'Ambrosio et al. Sep 2019 A1
20190351117 Cambronne et al. Nov 2019 A1
20190351118 Graichen et al. Nov 2019 A1
20200016309 Kallenbach et al. Jan 2020 A1
20200038567 Siess et al. Feb 2020 A1
20200060559 Edelman et al. Feb 2020 A1
20200069857 Schwammenthal et al. Mar 2020 A1
20200147283 Tanner et al. May 2020 A1
20200164125 Muller et al. May 2020 A1
20200164126 Muller May 2020 A1
20200253583 Brisken et al. Aug 2020 A1
20200312450 Agnello et al. Oct 2020 A1
20210268264 Stotz Sep 2021 A1
20210290087 Schlebusch Sep 2021 A1
20210290930 Kasel Sep 2021 A1
20210290933 Stotz Sep 2021 A1
20210339002 Schlebusch et al. Nov 2021 A1
20210339004 Schlebusch et al. Nov 2021 A1
20210346674 Baumbach et al. Nov 2021 A1
20210346675 Schlebusch et al. Nov 2021 A1
20210346676 Schlebusch et al. Nov 2021 A1
20210346677 Baumbach et al. Nov 2021 A1
20210346678 Baumbach et al. Nov 2021 A1
20210378523 Budde Dec 2021 A1
20210379359 Schellenberg Dec 2021 A1
20210379360 Schellenberg Dec 2021 A1
20210393944 Wenning Dec 2021 A1
20220016411 Winterwerber Jan 2022 A1
20220032032 Schlebusch et al. Feb 2022 A1
20220032036 Baumbach et al. Feb 2022 A1
20220047173 Stotz et al. Feb 2022 A1
20220050037 Stotz et al. Feb 2022 A1
20220072298 Spanier et al. Mar 2022 A1
20220076807 Agnello Mar 2022 A1
20220079457 Tuval et al. Mar 2022 A1
20220105339 Nix et al. Apr 2022 A1
20220126085 Farnan Apr 2022 A1
20220126086 Schlebusch et al. Apr 2022 A1
20220142462 Douk et al. May 2022 A1
20220161019 Mitze et al. May 2022 A1
20220361762 Lalancette Nov 2022 A1
20230173250 Stigloher Jun 2023 A1
20230191141 Wenning et al. Jun 2023 A1
20240011808 Winzer et al. Jan 2024 A1
20240074828 Wenning Mar 2024 A1
20240245902 Schlebusch et al. Jul 2024 A1
Foreign Referenced Citations (276)
Number Date Country
3 122 415 Jul 2020 CA
1192351 Sep 1998 CN
1222862 Jul 1999 CN
1202871 May 2005 CN
1661338 Aug 2005 CN
101128168 Feb 2008 CN
101208045 Jun 2008 CN
101214158 Jul 2008 CN
101351237 Jan 2009 CN
101448535 Jun 2009 CN
101460094 Jun 2009 CN
101579233 Nov 2009 CN
201437016 Apr 2010 CN
101711683 May 2010 CN
201658687 Dec 2010 CN
102421372 Apr 2012 CN
102803923 Nov 2012 CN
103328018 Sep 2013 CN
103857326 Jun 2014 CN
103957957 Jul 2014 CN
104105449 Oct 2014 CN
104188687 Dec 2014 CN
106104229 Nov 2016 CN
106333707 Jan 2017 CN
206007680 Mar 2017 CN
107530479 Jan 2018 CN
107632167 Jan 2018 CN
109939282 Jun 2019 CN
209790495 Dec 2019 CN
210020563 Feb 2020 CN
195 20 920 Dec 1995 DE
198 21 307 Oct 1999 DE
100 59 714 May 2002 DE
100 60 275 Jun 2002 DE
101 44 269 Mar 2003 DE
102 26 305 Oct 2003 DE
10 2006 001 180 Sep 2007 DE
10 2009 007 216 Aug 2010 DE
10 2009 011 726 Sep 2010 DE
10 2009 025 464 Jan 2011 DE
10 2009 047 845 Mar 2011 DE
10 2011 106 142 Dec 2012 DE
20 2011 110 389 Sep 2013 DE
10 2015 004 177 Oct 2015 DE
10 2015 219 263 Apr 2017 DE
10 2015 222 199 May 2017 DE
20 2015 009 422 Jul 2017 DE
10 2012 207 042 Sep 2017 DE
10 2016 013 334 Apr 2018 DE
10 2018 208 536 Dec 2019 DE
10 2018 208 862 Dec 2019 DE
10 2018 208 916 Dec 2019 DE
10 2018 208 927 Dec 2019 DE
10 2018 208 945 Dec 2019 DE
10 2018 210 076 Dec 2019 DE
10 2018 212 153 Jan 2020 DE
10 2018 213 151 Feb 2020 DE
10 2018 213 350 Feb 2020 DE
10 2018 220 658 Jun 2020 DE
10 2018 222 505 Jun 2020 DE
10 2020 102 473 Aug 2021 DE
11 2020 003 151 Mar 2022 DE
0 794 411 Sep 1997 EP
0 916 359 May 1999 EP
1 062 959 Dec 2000 EP
1 339 443 Nov 2001 EP
1 011 803 Sep 2004 EP
1 354 606 Jun 2006 EP
2 143 385 Jan 2010 EP
2 175 770 Apr 2010 EP
2 187 807 Jun 2012 EP
2 570 143 Mar 2013 EP
2 401 003 Oct 2013 EP
1 871 441 Nov 2014 EP
2 859 911 Apr 2015 EP
2 213 227 Aug 2016 EP
2 835 141 Aug 2016 EP
3 088 016 Nov 2016 EP
2 585 129 Mar 2017 EP
2 945 661 Nov 2017 EP
2 136 861 Dec 2017 EP
3 020 426 Dec 2017 EP
3 287 154 Feb 2018 EP
3 205 359 Aug 2018 EP
3 205 360 Aug 2018 EP
3 389 738 Aug 2019 EP
2 505 090 Dec 2019 EP
3 668 560 Jun 2020 EP
3 720 520 Oct 2020 EP
3 753 594 Dec 2020 EP
3 357 523 Jan 2021 EP
3 490 628 Feb 2021 EP
3 487 548 Mar 2021 EP
3 509 661 Mar 2021 EP
3 515 523 Mar 2021 EP
3 528 863 Mar 2021 EP
3 615 103 Mar 2021 EP
4 271 461 Mar 2021 EP
3 131 600 Jun 2021 EP
3 131 615 Jun 2021 EP
3 463 505 Sep 2021 EP
3 884 970 Sep 2021 EP
2 599 510 Oct 2021 EP
3 003 421 Oct 2021 EP
3 027 241 Oct 2021 EP
3 668 561 Oct 2021 EP
3 164 168 Dec 2021 EP
3 344 129 Dec 2021 EP
3 624 867 Mar 2022 EP
3 651 822 Mar 2022 EP
3 689 389 Mar 2022 EP
3 737 436 Mar 2022 EP
3 972 661 Mar 2022 EP
3 984 589 Apr 2022 EP
3 654 006 May 2022 EP
3 737 310 Jul 2022 EP
2 999 400 Aug 2022 EP
3 711 788 Aug 2022 EP
3 694 573 Sep 2022 EP
3 600 477 Oct 2022 EP
3 897 768 Oct 2022 EP
2 892 583 Jan 2023 EP
3 370 797 Jan 2023 EP
3 597 231 Jan 2023 EP
3 668 562 Jan 2023 EP
3 856 275 Jan 2023 EP
3 003 420 Feb 2023 EP
3 397 299 Feb 2023 EP
3 046 594 Mar 2023 EP
3 938 005 Apr 2023 EP
3 685 562 May 2023 EP
3 397 298 Jul 2023 EP
3 809 959 Jul 2023 EP
2 072 150 Sep 2023 EP
2 961 984 Sep 2023 EP
3 352 808 Sep 2023 EP
3 768 156 Sep 2023 EP
4 052 754 Oct 2023 EP
3 157 596 Nov 2023 EP
3 766 428 Nov 2023 EP
3 781 027 Nov 2023 EP
4 061 470 Nov 2023 EP
4 070 720 Nov 2023 EP
3 449 958 Dec 2023 EP
3 687 596 Dec 2023 EP
3 768 340 Dec 2023 EP
3 801 675 Jan 2024 EP
3 566 636 Feb 2024 EP
3 634 526 Feb 2024 EP
3 768 347 Feb 2024 EP
3 790 606 Feb 2024 EP
3 930 780 Feb 2024 EP
3 397 147 Mar 2024 EP
3 782 695 Mar 2024 EP
3 854 448 Mar 2024 EP
4 140 532 May 2024 EP
3 693 038 Jun 2024 EP
3 970 765 Jul 2024 EP
3 854 444 Sep 2024 EP
3 793 674 Oct 2024 EP
3 618 885 Nov 2024 EP
4 034 221 Nov 2024 EP
3 809 960 Dec 2024 EP
2 913 485 Jun 2022 ES
S59-080229 May 1984 JP
S61-125329 Jun 1986 JP
S62-113555 Jul 1987 JP
S62-204733 Sep 1987 JP
S62-282284 Dec 1987 JP
S64-68236 Mar 1989 JP
H02-055886 Feb 1990 JP
H02-234750 Sep 1990 JP
H05-079875 Mar 1993 JP
H06-218044 Aug 1994 JP
H07-047025 May 1995 JP
H08-057042 Mar 1996 JP
H08-066398 Mar 1996 JP
H08-327527 Dec 1996 JP
H10-052489 Feb 1998 JP
H10-505766 Jun 1998 JP
H11-239617 Sep 1999 JP
2000-512191 Sep 2000 JP
2001-037728 Feb 2001 JP
2001-506140 May 2001 JP
2001-276213 Oct 2001 JP
2002-525175 Aug 2002 JP
2003-019197 Jan 2003 JP
2003-047656 Feb 2003 JP
2003-062065 Mar 2003 JP
2004-515278 May 2004 JP
2005-028137 Feb 2005 JP
2005-192687 Jul 2005 JP
2006-528006 Dec 2006 JP
2007-222644 Sep 2007 JP
2008-511414 Apr 2008 JP
2006-518249 Aug 2008 JP
2008-178690 Aug 2008 JP
2009-504290 Feb 2009 JP
2009-240348 Oct 2009 JP
2010-518907 Jun 2010 JP
2012-520157 Sep 2012 JP
2013-128792 Jul 2013 JP
2014-524274 Sep 2014 JP
2015-514529 May 2015 JP
2015-514531 May 2015 JP
2015-515429 May 2015 JP
2015-122448 Jul 2015 JP
2015-527172 Sep 2015 JP
2015-181800 Oct 2015 JP
2016-002466 Jan 2016 JP
2016-509950 Apr 2016 JP
2017-500932 Jan 2017 JP
2017-176719 Oct 2017 JP
2017-532084 Nov 2017 JP
2019-523110 Aug 2019 JP
2020-072985 May 2020 JP
WO 92015239 Sep 1992 WO
WO 98043688 Oct 1998 WO
WO 00033047 Jun 2000 WO
WO 2006122001 Nov 2006 WO
WO 2010142286 Dec 2010 WO
WO 2010143272 Dec 2010 WO
WO 2012018917 Feb 2012 WO
WO 2012112378 Aug 2012 WO
WO 2013160443 Oct 2013 WO
WO 2014042925 Mar 2014 WO
WO 2014141284 Sep 2014 WO
WO 2014165635 Oct 2014 WO
WO 2015085220 Jun 2015 WO
WO 2016001284 Jan 2016 WO
WO 2016066180 May 2016 WO
WO 2016137743 Sep 2016 WO
WO 2017032751 Mar 2017 WO
WO 2017066257 Apr 2017 WO
WO 2017106190 Jun 2017 WO
WO 2017147291 Aug 2017 WO
WO 2017214118 Dec 2017 WO
WO 2018005228 Jan 2018 WO
WO 2018048800 Mar 2018 WO
WO 2018109038 Jun 2018 WO
WO 2018213089 Nov 2018 WO
WO 2019013794 Jan 2019 WO
WO 2019034670 Feb 2019 WO
WO 2019034775 Feb 2019 WO
WO 2019078723 Apr 2019 WO
WO 2019126721 Jun 2019 WO
WO 2019137911 Jul 2019 WO
WO 2019193604 Oct 2019 WO
WO 2019219883 Nov 2019 WO
WO 2019229210 Dec 2019 WO
WO 2019229220 Dec 2019 WO
WO 2019234145 Dec 2019 WO
WO 2019234146 Dec 2019 WO
WO 2019234148 Dec 2019 WO
WO 2019234149 Dec 2019 WO
WO 2019234151 Dec 2019 WO
WO 2019234152 Dec 2019 WO
WO 2019234153 Dec 2019 WO
WO 2019234161 Dec 2019 WO
WO 2019234162 Dec 2019 WO
WO 2019234163 Dec 2019 WO
WO 2019234164 Dec 2019 WO
WO 2019234166 Dec 2019 WO
WO 2019234167 Dec 2019 WO
WO 2019234169 Dec 2019 WO
WO 2019243582 Dec 2019 WO
WO 2020030686 Feb 2020 WO
WO 2020030706 Feb 2020 WO
WO 2020064707 Apr 2020 WO
WO 2020089429 May 2020 WO
WO 2020198280 Oct 2020 WO
WO 2020243756 Dec 2020 WO
WO 2022074136 Apr 2022 WO
WO 2022109590 May 2022 WO
WO 2022173970 Aug 2022 WO
WO 2023049813 Mar 2023 WO
Non-Patent Literature Citations (21)
Entry
Vollkron et al., “Advanced Suction Detection for an Axial Flow Pump”, Artificial Organs, 2006, vol. 30, No. 9, pp. 665-670.
Vollkron et al., “Development of a Suction Detection System for Axial Blood Pumps”, Artificial Organs, 2004, vol. 28, No. 8, pp. 709-716.
Atkinson et al., “Pulse-Doppler Ultrasound and Its Clinical Application”, The Yale Journal of Biology and Medicine, 1977, vol. 50, pp. 367-373.
Leguy et al., “Assessment of Blood Volume Flow in Slightly Curved Arteries from a Single Velocity Profile”, Journal of Biomechanics, 2009, pp. 1664-1672.
Lombardi et al., “Flow Rate Profiler: an instrument to measure blood velocity profiles”, Ultrasonics, 2001, vol. 39, pp. 143-150.
Mushi et al., “Identification of Fluidic Element Models to Simulate the Short-Term Baroreflex”, Proceedings of the 45th IEEE Conference on Decision & Control, San Diego, CA, Dec. 13-15, 2006, pp. 6.
Sinha et al., “Effect of Mechanical Assistance of the Systemic Ventricle in Single Ventricle Circulation with Cavopulmonary Connection”, The Journal of Thoracic and Cardiovascular Surgery, Apr. 2014, vol. 147, No. 4, pp. 1271-1275.
“Understanding Hot-Wire Anemometry”, Advanced Thermal Solutions, Inc., 2007, pp. 13-17.
Vieli, A., “Doppler Flow Determination”, BJA: British Journal of Anaesthesia, 1988, vol. 60, pp. 107S-112S.
Yuanyuan et al., “Characteristics Analysis for Doppler Ultrasound Blood Flow Signals”, China Medical Device Information, 5(1), Feb. 28, 1999, pp. 36-42.
Zhang, Dabiao et al., “Design of Microwave Velocity and Distance Monitor System”, Instrument Technique and Sensor, Hebei Normal University, Apr. 25, 2004, pp. 3.
Hertz Ph.D. et al, “Ultrasonic Engineering in Heart Diagnosis”, The American Journal of Cardiology, Jan. 1967, vol. 19, No. 1, pp. 6-17.
International Preliminary Report on Patentability and Written Opinion received in PCT Application No. PCT/EP2019/064807, dated Dec. 17, 2020 in 16 pages.
International Search Report and Written Opinion received in PCT Application No. PCT/EP2019/064807, dated Oct. 17, 2019 in 21 pages.
Kong et al., “A Stein Equation Approach for Solutions to the Diophantine Equations,” 2010 Chinese Control and Decision Conference, Xuzhou, May 26, 2010, pp. 3024-3028.
Koseli et al., “Online Viscosity Measurement of Complex Solutions Using Ultrasound Doppler Velocimetry”, Turk J Chem, Jan. 2006, vol. 30, pp. 297-305.
McCormick et al., “Resolution of a 2/spl pi/ Ambiguity Problem in Multiple Frequency Spectral Estimation,” in IEEE Transactions on Aerospace and Electronic Systems, Jan. 1995, vol. 31, No. 1, pp. 2-8.
Syrmos et al., “A Generalized Bezout Equation in Output Feedback Design,” Proceedings of the 31st IEEE Conference on Decision and Control, Tucson, AZ, USA, Dec. 1992, vol. 4, pp. 3590-3594.
Udesen et al., “A Simple Method to Reduce Aliasing Artifacts in Color Flow Mode Imaging”, IEEE Ultrasonics Symposium, 2005, Rotterdam, The Netherlands, Sep. 18-21, 2005, pp. 1352-1355.
Murali, Akila, “Design of Inductive Coils for Wireless Power Transfer to Pediatric Implants”, A graduate project submitted in partial fulfillment of the requirements for the degree of Master of Science in Electrical Engineering, California State University, Northridge, May 2018, pp. 37.
HeartMate 3™ Left Ventricular Assist System, Instructions for Use, Thoratec Corporation, Aug. 2017, pp. 536. [Uploaded in 3 parts].
Related Publications (1)
Number Date Country
20220039669 A1 Feb 2022 US